loader image
Monday, June 17, 2024
82.4 F
We Welcome your Press Release
- Advertisement -

Doctors Hospital at Renaissance Participates in Zika Vaccine Research Trial

Translate to Spanish or other 102 languages!

Mega Doctor News 

- Advertisement -

EDINBURG, TX — Leidos Biomedical Research, Inc. has awarded a subcontract to the Research Institute at Doctors Hospital at Renaissance to facilitate a Zika vaccine trial in Edinburg, Texas.

Leidos Biomed, which operates the Frederick National Laboratory in Frederick, Md., manages a number of Zika response efforts funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health (NIH).

The Research Institute at Doctors Hospital at Renaissance Health System (DHR) is recruiting healthy people between the ages of 15 and 35 years to participate in a clinical trial in which they might receive an experimental vaccine against the Zika Virus. This research is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) part of the National Institutes of Health (NIH) based in Bethesda, Maryland. The Zika vaccine does not contain live or inactivated Zika virus therefore does not contain infectious material and cannot cause Zika infection. Initial findings indicate the vaccine is safe and able to induce a neutralizing antibody response against the Zika virus. A key goal of the trial at DHR is to determine if the vaccine can effectively prevent disease caused by Zika infection.

- Advertisement -

A Zika vaccine is urgently needed to prevent the often-devastating birth defects that can result from Zika virus infection during pregnancy. It could also prevent symptoms of the disease such as: low fever with rash, pain in the joints or conjunctivitis. The infection is spread through the Aedes aegypti mosquito, or through sexual contact. There are no specific treatments or vaccines against Zika virus.  From 2007 to 2016, the virus spread to the east, across the Pacific Ocean to the Americas, which led to the Zika virus epidemic 2015-16.

The Research Institute at Renaissance is made up of a group of professionals of excellent academic level and vast experience in research studies under the direction of Lisa Treviño, PhD and other physicians at DHR.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health: Pioneering Alzheimer’s Treatment Breakthrough South of San Antonio

DHR Health, a leader in healthcare innovation, proudly announced today its groundbreaking achievement as the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved medication for the early treatment of Alzheimer’s disease. This milestone demonstrates their expertise and is a significant advancement in healthcare for the Rio Grande Valley.

FDA Approves First CRISPR Gene Therapy to Treat Sickle Cell Disease

Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older.

DHR Health Brownsville Leads the Way in Minimally Invasive Robotic Surgery

DHR Health stands at the forefront of minimally invasive robotic surgery in South Texas, exemplified by its Institute of Robotic Surgery, which successfully completes over 1,000 robotic cases annually. With the recent inauguration of DHR Health Brownsville, this advanced expertise in Minimally Invasive Surgical procedures is extending its reach to the lower Rio Grande Valley. In a groundbreaking milestone last month, Dr. Rene Luna conducted DHR Health Brownsville's inaugural Robotic Surgery.

Pieology Donates 100 Gallons Of Hand Sanitizer To DHR Health

Agustin Guzman and Juan Garza of Pieology said they receive so much support from their communities and businesses, including DHR Health employees who love their pizza, and wanted to give back in a way that offers the hospital system some additional resources to help keep staff and patients protected from the spread of COVID-19 or any other viruses.
- Advertisement -